MICROCARB INC has a total of 36 patent applications. Its first patent ever was published in 1991. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are OHIO MED COLLEGE, ROYAL FREE HOSP SCHOOL MED and CHILDREN S HOSPITAL OAKLAND RE.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 9 | |
#2 | Canada | 7 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | United States | 3 | |
#5 | China | 2 | |
#6 | Finland | 2 | |
#7 | Israel | 2 | |
#8 | Mexico | 2 | |
#9 | Norway | 2 | |
#10 | New Zealand | 2 | |
#11 | Australia | 1 | |
#12 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Measurement | |
#5 | Machines | |
#6 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Climate change adaptation technologies | |
#4 | Microorganisms | |
#5 | Peptides | |
#6 | Measuring microorganism processes | |
#7 | Analysing materials | |
#8 | Unspecified technologies | |
#9 | Microorganisms | |
#10 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Krivan Howard C | 21 |
#2 | Pace John L | 9 |
#3 | Samuel James E | 9 |
#4 | Frey Steven M | 9 |
#5 | Walker Richard I | 8 |
#6 | Lingwood Clifford A | 6 |
#7 | Nilsson Bo | 6 |
#8 | Samuels James E | 3 |
#9 | Norberg Nils Thomas | 2 |
#10 | Pace J L | 2 |
Publication | Filing date | Title |
---|---|---|
MX9702432A | Methods for producing enhanced antigenic helicobacter sp. and vaccines comprising same. | |
CN1169751A | Methods for producing enhanced antigenic helicobacter SP. and vaccine camprising same | |
US5466681A | Receptor conjugates for targeting penicillin antibiotics to bacteria | |
US5552144A | Immunogenic shiga-like toxin II variant mutants | |
WO9400149A1 | ADHESIN-OLIGOSACCHARIDE CONJUGATE VACCINE FOR $i(HAEMOPHILUS INFLUENZAE) | |
CA2138765A1 | Recombinant haemophilus influenzae protein and nucleotide sequence encoding same | |
WO9322423A1 | Nutrient phospholipids for pathogenic bacteria | |
CA2132953A1 | Monospecific polyclonal antibodies to shiga-like toxins | |
EP0563256A1 | Use of host cell phospholipids for inhibiting bacterial colonization | |
WO9210936A1 | ADHESIN-OLIGOSACCHARIDE CONJUGATE VACCINE FOR $i(HAEMOPHILUS INFLUENZAE) | |
WO9211367A2 | Lipid receptors for microorganisms and corresponding adhesins, dna sequences encoding adhesins, and use thereof |